increased pancreatic islet cell carcinoma incidence_Tg(Ins2-Tag*,-flpe)#Gne/0

http://metadb.riken.jp/0010348IC57BL6JTgIns2TagflpeGne0TgIns2TagflpeGne

increased pancreatic islet cell carcinoma incidence_Tg(Ins2-Tag*,-flpe)#Gne/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion, Genentech
  http://metadb.riken.jp/db/mgi_rdf/MGI:5441545

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Ins2-Tag*,-flpe)#Gne/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Ins2-Tag*,-flpe)#Gne

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased pancreatic islet cell carcinoma incidence
  http://purl.obolibrary.org/obo/MP_0010348

文献

http://purl.org/net/cito/citesAsAuthority

• Mallika. Singh, et.al., Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models., The Journal of pathology, 2012, 227
  http://rdf.ncbi.nlm.nih.gov/pubmed/22611036